There are many classes of chemicals widely used in a number of commercial and industrial processes having a potential to affect adversely the nervous system. Because of their relative sensitivity to some agents and general noninvasive characteristics, functional measurements of neurotoxicity are being used with greater frequency, especially at the level of hazard identification. The neurobehavioral test battery used by the National Toxicology Program (NTP) includes motor activity, fore-and hindlimb grip strength, acoustic startle response, responsiveness to an adverse thermal stimulus and general health and clinical measures (body weight, autonomic signs, tremor, convulsions). These tests have been used in nearly 40 studies involving various dosing regimens with rats and mice. The NTP battery shows several salient features of an effective screen, including the ability to differentiate known neurotoxicants from nonneurotoxicants, identify certain types of neurological sequelae or profiles of neurotoxic effects and construct dose-and time-response data in a screening context. The extent to which the NTP battery has predictive validity is still being evaluated.
chemical status. Silent or latent damage masking the consequences of the initial exposure may lead to additional exposure and increased dosage.
Functional indices of neurotoxicity, which include alterations in neurochemistry, neurophysiology and neurobehavior, have received increased attention by neurotoxicologists in recent years (1 8). There are numerous examples underscoring the importance of functional alterations following exposure to agents with known neurotoxicity. Accidental exposure in the environment or workplace to a wide variety ofagents, including heavy metals, pesticides, and solvents, is known to have deleterious effects on sensory, motor and/or cognitive processes of humans. At the present time, the number of chemicals causing behavioral or neurological alterations is not known. Anger (2) reported that of 588 chemicals listed by the American Conference ofGovernmenta1 Industrial Hygienists in their 1982 publication on thkshold limit values for chemical substances and physical agents in the workplace, 28% or 167 have threshold limit values based in some manner on the neurological or behavioral endpoints. The actual incidence of problems associated with exposure to low levels of neurotoxicants is not known since many of the signs and symptoms are vague, ambiguous, or subjective. Therefore, there is a potentially large possibility for subtle and uncharacterized neurotoxic effects in the population. 96 Behavioral procedures have been used in pharmacology and toxicology for several years to measure the effects of chemicals on the nervous system. Behavior can be defined as the net sensorimotor and integrative processes occumng in the nervous system and it follows that an alteration in behavior might be a relatively sensitive indicator ofexposure. Thus, under some circumstances, the dose effect curve for some behavioral alterations might lie to the left of other endpoints of toxicity. Behavioral endpoints are also important in toxicological studies since they are generally noninvasive and can be used to assess subjects repeatedly during the course of chronic exposure. This may be crucial if exposure to a chemical produces a subtle loss of brain capacity, such as that seen normally with aging. Because of the potential uxfulness of behavioral endpoints in the assessment of chemicals for neurotoxicity, regulatory agencies such as the Environmental Protection Agency (EPA) (22) have promulgated guidelines for several behavioral procedures, including a functional observational battery, motor activity, schedule-controlled behavior and delayed neurotoxicity of organophosphorous substances. TYPES OF NEUROBEHAVIORAL TESTS One method of classifying behavioral procedures is according to their desired use in the experiment (1 9). Techniques intended to measure the presence or absence of an effect are usually different from those used to assess the degree of toxicity or the lowcst level required to produce an effect. Screening procedures designed to test large numbers of animals may not require extensive training of the animals and are relatively simple to perform. However, these techniques are frequently labor intensive, often require subjective (unautomated) measures, generally yield quanta1 data, and may not be as sensitive to subtle effects as other tests.
Some tests may be designed to determine more definite or precise endpoints and are usually employed in studies concerning mechanism of action or the estimation of the least effective dose. These procedures are sometimes called secondary tests and may require special equipment, pretraining of experimental animals, or the use of motivational factors such as negative reinforcement or food deprivation. Secondary procedures are usually automated and generate graded or continuous data making them amenable to repeated measures, experimental designs and parametric data analyses.
Another way of classifying behavioral procedures is based upon the neurobehavioral functions that might be affected by exposure to a neurotoxicant. That is, chemicals can affect a wide range of behavioral and neurological functions, including motor, sensory, cognitive, CNS excitability and general changes (2, 5 , 26) . Table I contains a summary of behavioral and neurological signs that have been reported in humans exposed to various types of neurotoxicants. Table I1 summarizes general types of behavioral tests that have been used to measure neurotoxicant-induced changes in animal behavior.
Frequently, behavioral toxicologists employ several tests in an attempt to generate a profile ofeffects permitting a more accurate characterization of a chemical's activity. In some cases, a single test requiring the successful integration of intact subsystems, sometimes referred to as an apical test, is appropriate (3). An example of an apical test is performance on an operant schedule of reinforcement. Such a procedure typically uses intermittent reinforcement of a defined response and establishes a dependency between the occurrence of a specific response such as a lever press and the presentation of a specific stimulus such as food. Deficits in operant responsing produced by exposure to a chemical may be due to alterations in any one or more neurobehavioral functions (i.e., sensory, motor, motivational, associative). Cabe and Eckerman (4) have characterized the determination of chemical effects on learning as "apical." That is, an effect on learning might account for observed alterations in behavior mediated by nonassociative processes.
APPROACHES TO THE TESTING OF ANIMALS FOR
The need to develop a strategy to assess chemicals for potential neurotoxicity has been recognized by many expert panels and groups (8, (23) (24) (25) 27) . It is widely accepted that, because of the limited toxicological information available for most compounds, a toxicity testing strategy must be able to evaluate many different kinds of chemicals. In accordance with recommendations made by the National Academy of Sciences in 1975 (23), many laboratories have adopted a sequential or tiered level of testing of chemicals for neurotoxicity permitting at any step during the progression a decision about rejection, acceptance or continuation of the assessment. In most cases, functional endpoints such as behavior are favored in the provisional assessment of chemicals since they are widely regarded as an indicator of the net sensory, motor and integrative processes occumng in the central and peripheral nervous system. Therefore, it is assumed that alterations in behavior following exposure to environmental agents might be an indicator of nervous system toxicity. Functional indicators of neurotoxicity are frequently made in conjunction with other endpoints, such as neuropathology or neurochemistry. Table 111 outlines a general strategy for the nzu- rotoxicological assessment of chemicals. The purpose of testing at the first tier or level is to determine if a chemical might produce neurotoxicity following exposure, i.e., hazard detection (14) . In this case, there may be little existing information concerning the potential neurotoxicity of a chemical. First tier assessment of chemicals usually consists of using some type of functional observational battery. Observational batteries for rodents have been used by many investigators to assess chemicals for neurotoxicity (1, 6, 7, 12, 15) and have been recommended by several expert panels, including the Food A decision to test at the second tier is based upon available data suggesting that a chemical produces neurotoxicity. The information used to make a decision to test a chemical can come from a variety of sources, including neurotoxicological data al- ready existing in the literature, structure activity relationships, data from first tier testing (functional observational battery) or following reports of neurotoxicity from humans exposed to. the chemical.
CHEMICAL-INDUCED NEUROTOXICITY
Testing at this level is designed to help ascertain whether or not the nervous system is the primary target for the chemical and determine dose-and timeeffect relationships using relatively sensitive endpoints. Functional testing at the secondary level is sometimes done in conjunction with other procedures, particularly neuropathology.
There is a third level of testing in which previous data suggest a specific neurotoxic effect (i.e., sensory defect, cognitive loss) and subsequent experiments are performed to characterize or study the mechanism of action associated with a neurotoxic agent. Such tests may also be useful in the determination of a no-effect level.
SECONDARY LEVEL TESTING-THE NEUROBEHAVIORAL TEST BATTERY OF THE NATIONAL TOXICOLOGY PROGRAM
The National Toxicology Program (NTP) was established in 1978 to provide scientific information concerning the toxic effects of chemicals and develop and improve methods for testing ofchemicals for potential toxicity. Compounds are selected by the NTP for study based on widespread human exposure or because existing data on their toxic effects are inadequate. Some chemicals may be selected because there is a need for information about structurally related chemicals likely to affect human health. Other criteria include the amount produced, significant physical and chemical properties, interest by regulatory and research agencies and possible public health significance.
The battery of neurobehavioral tests used by the NTP is summarized in Table IV and was selected on the basis of a validation study in which several doses of 8 chemicals known to produce different neurotoxic sequelae were repeatedly assessed in rats during a 15 week subchronic dosing study and for up to 6 weeks after cessation of exposure (13) . Behavioral procedures used in subsequent NTP work were selected on the basis of their ability to detect dose-dependent toxicant-induced changes in behavior, formulate a profile of relative changes in sen- the activity of single rats. Because these units do not differentiate vertical from horizontal movements or large from small (e.g., grooming) movements, the measure was labelled undifferentiated motor activity. Each unit was housed in a separate, sound-attenuated cubicle of a 2.5 cm thick plywood cabinet. Each cubicle had its own ventilation system. Each rat was placed in a clear plastic cage (27.9 x 17.8 x 12.7 cm) with a stainless steel grill top. The cage and its occupants were centered above the low-intensity radiofrequency field of the activity monitor. The outer door of the cabinet was closed, leaving the rat in a dark environment, and activity was mon- TILSON TOXICOLOGIC PATHOLOGY itored for 10 min. Counts were accumulated over the 10 min test period. Animals were run at approximately the same time each day. Box and run times were counterbalanced among groups. Other means of detecting movement, such as the use of photocells (21), are also useful in studying neurotoxicant-induced changes in motor activity.
Foreand ilindliriib Grip Slrenglhs. The apparatus described by Meyer et al (9) was used to measure fore-and hindlimb grip strength sequentially in each rat. The apparatus consists of a Plexiglas platform with two 7.6 cm vertical guides mounted on the entire length of the surface to form a horizontal adjustable channel. Two push-pull strain gauges (Chatillon, Model DPP 1 .O kg) were secured in the horizontal attitude, one at each end of the platform, on vertically and horizontally adjustable stands. A triangular forelimb grip bar (a brass rod 0.3 cm in diameter, each side 7.6 cm long) was attached to the front strain gauge that was set to opcratc in the pull mode. A hindlimb grip T-bar (1 2.7 x 0.3 cm) was attached to the rear strain gauge that was set to operate in the push mode. The forelimb grip bar was aligned 1.9 cm above the surface and the edge of the platform. The hindlimb grip bar was aligned horizontally with the platform and positioned 1.4 cm from its edge.
After each strain gauge was zeroed, the rat was placed in the channel with both forepaws inside the front triangular grip bar. When the rat gripped the bar, it was steadily pulled backwards by the tail until its grip was broken. The rat was pulled farther backwards until its hindpaws gripped the rear T-bar, and this action was continued until the hindlimb grip was broken. Readings on each strain gauge were recorded (to the nearest g), the strain gauges were zeroed, and the rat retested until readings on three successive trials were obtained. An average of the three readings was used for statistical analysis. Modification of the procedure of Meyer et al (9) has been reported by other groups (10, 12) .
TliermalSensitivify. The rat was placed in a horizontally positioned cylinder (diameter chosen to fit size of rat) that had a 1 cm slot running half the length of the bottom of the cylinder. To prevent escape, the front end of the cylinder was blocked except for a nose hole in the center; the tail was allowed to hang freely from the slot. The test was started after the rat had acclimated to the cylinder as judged by the absence of struggling (usually 5-10 sec). The tip of the tail (5 cm) was immersed in a 100 ml beaker of water taken from a nearby water bath maintained at 55°C. The time the rat took to raise its tail out of the hot water was measured to the nearest 0.1 sec with a stopwatch. Each rat was given one trial. In some studies, a hot-plate proce-dure has been used to measure pain sensitivity in rats (21).
Sfarfle. Each rat was placed on a Plexiglas platform (1 2.7 x 12.7 x 0.6 cm) mounted on a Model UC3 universal transducer (Statham Instruments Co., Oxnard, CA) attached to a 1 lb load assembly. Output from the transducer went to a solid-state electronic instrument to measure the amplitude of the startle response. Each rat was acclimated to the platform for at least 10 sec and when it was not moving, a 1 10-dB, 5-kHz tone having a duration of 100 msec was presented. Background noise in the room was 35 dB. Constant noise from the loudspeaker brought the level to 53 dB at the position of the rat on the platform. Each rat generally received only one trial, and the data were transformed to their logarithms (base 10) to homogenize variances for the statistical analysis. In the absence of a measurable response, up to two additional trials were given. If no response was elicited on these trials, an arbitrary score of 1.0 was assigned. In some studies, different transducing systems or repeated presentations of the eliciting stimulus have been used (21).
The Eflecfs of Acrylamide
An example of the use of the NTP neurobchavioral battery can be found in the work of Pryor et a1 (13) in which male, adult Fischer-344 rats were dosed by gavage repeatedly 5 days per week for 13 weeks with 0,6.6,9.6 and 13.8 mg/kg ofacrylamide monomer. Doses are proportions (1116, 1/8, 114) of the calculated LD20 determined during a 28-day repeated dosing experiment. Acrylamide is a neurotoxicant known to produce a central-peripheral dying back axonopathy, which results in a progressive muscle weakness and sensory disturbances in the extremities (1 7).
The highest dose (1 3.8 mg/kg) of acrylamide resulted in no mortality during the 15 weeks ofdosing or during the 6 week recovery period following cessation of dosing. Acrylamide caused a significant decrease in weight gain, an effect clearly evident at the highest dose after 15 weeks of dosing (Fig. 1) . Decreases in the magnitude of the acoustic startle response were also observed in animals receiving 9: 6 or 13.8 mg/kg after 12 and 15 weeks of dosing; this response 'quickly. recovered after cessation of dosing. Repeated dosing with acrylamide had no significant effect on spontaneous motor activity or on responsiveness to an aversive thermal stimulus (pain sensitivity).
The most prevalent effect of acrylamide was on grip strength (Fig. 2) . Forelimb grip strength was significantly reduced by acrylamide at 12 and 15 weeks of dosing with decreases seen in animals receiving 13.8 mg/kg. Significant decreases in hind-vol. 18 limb grip strength were observed in rats receiving 13.8 mg/kg after 6 weeks of dosing, while rats receiving 9.6 mg/kg had a significantly decreased hindlimb grip strength after 15 weeks of dosing. Some recovery of hindlimb function was observed 6 weeks after cessation of exposure.
As discussed by Pryor et a1 (13) , the effects observed with acrylamide agree well with other reports in the literature indicating that acrylamide produces a progressive neuromotor deficit without effects on responsiveness to pain. These changes were dosedependent and occurred at doses lower than those required to produce other signs of toxicity (i.e., changes in body weight, decreases in motor activity). Decreases in the magnitude of the acoustic startle response occurred relatively late during dosing and the ncuromuscular weakness present at that time might account for this impaired response.
Although histological measurements were not done in the Pryor et a1 (1 3) study, another by Tilson et a1 (20) dosed rats with 10 mg/kg acrylamide for 13 weeks. This dosing regimen produced significant decreases in the hindlimb extension response and significant morphological changes in the peripheral and/or central nervous system (Fig. 3) . Acrylamidetreated animals showed early signs of nerve fiber degeneration consisting of distal degeneration of large-diameter myelinated fibers with the appearance of clusters of small regenerating myelineated fibers in peripheral nerves. 
Studies 011 Other Agents Using the NTP Battery
Including acrylamide, 37 chemicals and 1 physical factor (microwaves) have been assessed for neurotoxicity in the NTP neurobehavioral battery. The NTP battery successfully identified several neurotoxicants known to produce axonopathy [acrylamide, carbon disulfide, n-hexane (rats), 2,Shexanedione, tricresylphosphate], myelinopathy (tri-and tetraethyl tin), neuronopathy (methylmercury) or act as a nerve poison (chlordecone), convulsant (Soman) or inhibitor of acetyl cholinesterase (Trichlorfon) in humans (Table V) . In addition, it detected effects produced by triethyl and trimethyl lead (diffuse neuronal damage in the central nervous system), chloroprene (an imtant), and polybrominated biphenyls (neuromuscular), all ofwhich are believed to be neurotoxic in humans (Table VI) . Moreover, it identified several compounds [N-methylolacrylamide, D-glaucine, benzonitrile, 2,4-dichlorophenoxyacetic acid, tetrakis hydroxy methyl phosphonium chloride and 4,4-thiobis-(6-t-butyl-m-cresyl)] as producing neurotoxicity in rats and, therefore, potentially neurotoxic in higher animals. The battery also found that pre-and/or postnatal exposure to benzene, chlordecone, monosodium glutamate and triethyltin resulted in measurable behavioral changes during maturation, suggesting that developmental exposure to these agents should bc avoided.
Where tested, the NTP battery was capable of detecting dose-and/or time-dependent effects (acrylamide, benzonitrile, chlordecone, chloroprene, 2,4-dichlorophenoxyacetic acid, D-galucine, n-hexanedione, triethyl lead, trimethyl lead, methylmercury, N-methylolacrylamide, polybrominated biphenyls, tetrakis hydroxy methyl phosphonium chloride, tri-and tetraethyl tin, trichlorfon, tricresylphosphate). In addition, it was capable of detecting differences in responses between mice and rats (benzonitrile, tricresylphosphate, polybrominated biphenyls) and males and females (benzonitrile, postnatal monosodium glutamate, trichlorfo n) .
The NTP battery for rats did not find neurotoxicity with agents having little or no neurotoxicity in adult humans (arsenate sodium, arsenic trioxide, o-benzyl-p-chlorophenol, cobalt sulfate, silver nitrate, perinatal microwave exposure) (Table VII) . It found that the nonneurotoxic congener of acrylamide, bisacrylamide, was inactive and failed to confirm any neurotoxicity following aspartame, an agent suspected of being a proconvulsant in humans. Several compounds (barium chloride, methyl bromide, selenate sodium, toluene) reportedly produce nonspecific neurological changes in humans and were not identified as neurotoxic in rats at the doses and routes of exposure used. The NTP battery did not detect ototoxicity associated with repeated dosing to monosodium salicylate, encephalopathy produced by lead acetate, or delayed neuropathy produced by tri-o-cresylphosphate, an effect difficult to obsepe in rodent species (1 6).
SUMMARY AND CONCLUSIONS
The NTP battery of neurobehavioral tests appears to meet many criteria of a successful screening battery and to be able to distinguish known neurotox- 
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Chloroprene ( icants from nonneurotoxicants, at least as it pertains to the rat. In some cases, the profile of effects generated in the battery would be helpful in classifying the neurotoxicant or identifying the next step in the assessment of the compound. The NTP battery is capable of measuring dose-and time-dependent changes in behavior and is amenable to many different dosing regiments. It is capable of detecting differential responsiveness between species, sexes and ages of animals. The ability to detect unknown neurotoxicants in humans based on data from rodents, or its predictive validity, remains to be determined. There are several agents [N-methylolacrylamide, D-glaucine, benzonitrile, 2,4-dichlorophenoxyacetic acid, tetrakis hydroxy methyl phosphonium chloride, 4,4-thiobis-(6-t-butyl-m-cresol) and postnatal exposure to benzene, monosodium glutamate, and triethyl tin] that were identified as suspected neurotoxicants by the NTP battery and deserve further study. 
